Continued circulation of mpox: an epidemiological and phylogenetic assessment, European Region, 2023 to 2024
Vaughan, Aisling M.
Afzal, Mohammed
Nannapaneni, Priyanka
Leroy, Mathias
Andrianou, Xanthi
Pires, Jeffrey
Funke, Silvia
Roman, Celine
Reyes-Uruena, Juliana
Aberle, Stephan
Aristodimou, Aristos
Aspelund, Gudrun
Bennet, Kirsty F.
Bormane, Antra
Caraglia, Anna
Charles, Hannah
Chazelle, Emilie
Christova, Iva
Cohen, Orna
Constantinou, Costas
Couvreur, Simon
Diaz, Asuncion
Fabiánová, Kateřina
Ferraro, Federica
Grenersen, Marte Petrikke
Grilc, Eva
Hannila-Handelberg, Tuula
Hvass, Anne Kathrine
Igoe, Derval
Jansen, Klaus
Janță, Denisa
Kaoustou, Styliani
Koch, Anders
Kosanovic Licina, Mirjana Lana
Krumova, Stefka
Labutin, Anton
Lachmann, Raskit
Lecompte, Amaryl
Lefrançois, Rémi
Leitena, Viktorija
Liitsola, Kirsi
Mlinarić, Ivan
Mor, Zohar
Neary, Martha
Novacek, Alina
Øgle, Magnus Wenstøp
Orlíková, Hana
Papadima, Kalliopi
Rehn, Moa
Sadkowska-Todys, Malgorzata
Sîrbu, Anca
Sondén, Klara
Suárez, Berta
Thordardottir, Marianna
Vasconcelos, Paula
Martins, Joao Vieira
Zakrzewska, Karolina
Widdowson, Marc-Alain
Gossner, Céline M.
During the summer of 2023, the European Region experienced a limited resurgence of mpox cases following the substantial outbreak in 2022. This increase was characterised by asynchronous and bimodal increases, with countries experiencing peaks at different times. The demographic profile of cases during the resurgence was largely consistent with those reported previously. All available sequences from the European Region belonged to clade IIb. Sustained efforts are crucial to control and eventually eliminate mpox in the European Region.
